Valuation : cbdMD, Inc.

Market Cap 5.36M 4.61M 4.37M 3.96M 7.43M 512M 7.47M 51.9M 19.96M 260M 20.12M 19.67M 823M P/E 2026 *
-1.45x
P/E 2027 * -2.52x
Enterprise Value 5.36M 4.61M 4.37M 3.96M 7.43M 512M 7.47M 51.9M 19.96M 260M 20.12M 19.67M 823M EV / Sales 2026 *
0.24x
EV / Sales 2027 * 0.19x
Free-Float
90%
Yield 2026 *
-
Yield 2027 * -
1 day+1.05%
1 week+1.35%
Current month-1.63%
1 month-17.61%
3 months-30.95%
6 months-31.34%
Current year-64.30%
1 week 0.47
Extreme 0.4744
0.5
1 month 0.45
Extreme 0.4521
0.62
Current year 0.45
Extreme 0.4521
1.34
1 year 0.45
Extreme 0.4521
2.56
3 years 0.45
Extreme 0.4521
13.84
5 years 0.45
Extreme 0.4521
820.8
10 years 0.45
Extreme 0.4521
2,606.4
Manager TitleAgeSince
Chief Executive Officer 47 01/03/2023
Chief Tech/Sci/R&D Officer - 01/01/2019
Chief Tech/Sci/R&D Officer 45 -
Director TitleAgeSince
Director/Board Member 41 01/03/2017
Director/Board Member 66 19/04/2019
Chairman 60 03/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
14/4/26 Free

Director

1,572 0.0150%
14/4/26 Free

Director

1,572 0.0150%
14/4/26 Free

Director

1,572 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%+1.35%-31.04%-95.70% 5.36M
-0.07%-2.37%+48.37%+88.41% 1,001B
-0.19%-3.45%+48.88%+63.37% 642B
+1.13%+0.45%+16.98%+72.85% 451B
-0.38%-3.59%+28.24%+35.57% 340B
-0.09%-13.54%+10.08%+26.87% 263B
-0.43%-2.48%-2.07%+11.48% 247B
-0.81%-13.32%+34.04%+44.80% 207B
-3.44%-7.51%-20.08%-59.58% 197B
-0.50%-4.65%+22.15%+86.88% 180B
Average -0.34%-5.04%+15.55%+27.50% 352.63B
Weighted average by Cap. -0.22%-4.65%+30.13%+55.90%

Financials

2026 *2027 *
Net sales 21.92M 18.89M 17.89M 16.21M 30.41M 2.09B 30.57M 212M 81.69M 1.07B 82.33M 80.53M 3.37B 28.6M 24.64M 23.33M 21.14M 39.67M 2.73B 39.87M 277M 107M 1.39B 107M 105M 4.39B
Net income -3.33M -2.87M -2.72M -2.46M -4.62M -318M -4.65M -32.29M -12.42M -162M -12.51M -12.24M -512M -4.95M -4.26M -4.04M -3.66M -6.86M -473M -6.9M -47.92M -18.43M -240M -18.58M -18.17M -760M
Net Debt - -
Logo cbdMD, Inc.
cbdMD, Inc. is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by natural compounds. Its hemp-derived cannabinoids, include full-spectrum cannabidiol (CBD) formulations, hemp-derived Delta-9 THC products and a range of functional products designed to address key wellness needs, such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. It operates a multi-brand portfolio anchored by its flagship cbdMD line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Its Paw CBD pet-wellness brand provides tinctures, chews, and topicals for dogs and cats. Its ATRX platform offers non-cannabinoid functional ingredients such as functional mushrooms. Its Herbal Oasis (Oasis) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms.
Employees
42
Date Price Change Volume
12/09/26 USD 0.4820 +0.84% 10,014
10/09/26 USD 0.4780 -2.83% 71,617
09/09/26 USD 0.4919 -1.56% 71,766
08/09/26 USD 0.4997 +5.07% 34,356
04/09/26 USD 0.4756 -1.12% 83,692
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.4780
Average target price
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. YCBD Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!